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Previewsdegeneration in SBMA? Will amelioration
of the disease by targeting muscle
uncover other CNS manifestations?
Answering these questions will help in
translating this potential treatment option
into effective treatment in patients.
In summary, the reports by Cortes
et al. (2014) and Lieberman et al. (2014)
emphasize the role of skeletal muscle
as an important contributor to SBMA
pathogenesis and underscore the impor-
tance of exploring approaches targeting
peripheral tissues for treatment.
Clearly, in this disease the muscle
matters.
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Microglia are highly dynamic components of the innate immune system. In this issue of Neuron, Elmore et al.
(2014) report that global depletion of microglia triggers mobilization of latent microglial progenitors
throughout the CNS, resulting in rapid repopulation.There is a common misconception that
the adult CNS has a limited capacity for
repair and regeneration. While this is true
for most neuronal populations, many
types of glial cells exhibit remarkable
homeostasis and strive to maintain a
constant density in response to internal
or external perturbations. Understanding
how this process of cellular maintenance
is regulated, and identifying the progeni-
tors responsible for replenishing distinct
classes of glia, could lead to new strate-
gies for speeding recovery from injuryand limiting the abnormal cellular prolif-
eration that leads to brain cancer. In this
issue of Neuron, Elmore et al. (2014)
describe a new method to deplete micro-
glia from the adult CNS and use this
approach to investigate how homeostasis
of microglia is achieved and the broader
roles of these ubiquitous glial cells in con-
trolling behavior.
Unlike other glial cells (astroglia, oligo-
dendroglia), microglia are formed outside
the developing CNS from hematopoietic
progenitors in the yolk sac and migrateinto the CNS before the blood-brain bar-
rier (BBB) is formed (Kierdorf et al.,
2013). There they expand through prolif-
eration to establish a grid-like distribution
throughout the CNS. Microglia are crucial
for the innate immune response and
secrete numerous cytokines and chemo-
kines to regulate tissue repair and can
transform into highly migratory cells that
engulf dead cells and debris, playing a
crucial role in CNSdevelopment, recovery
from injury, and progression of disease.
Recent studies suggest that these glial82, April 16, 2014 ª2014 Elsevier Inc. 253
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Figure 1. Inhibition of CSFR1 Induces Death of Microglia in the Adult CNS that Are Repopulated through Recruitment of Latent Progenitors
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Previewscells also engage in local control of excit-
atory synapses, by pruning synapses and
controlling dendritic spine density (Paoli-
celli et al., 2011; Schafer et al., 2012), sug-
gesting that they play an important role
in remodeling neural circuits.
Microglia are known to require activa-
tion of colony-stimulating factor receptor
1 (CSFR1), a receptor tyrosine kinase,
for proliferation and survival during early
development; mice that lack this receptor
do not formmicroglia and rarely survive to
adulthood (Erblich et al., 2011; Ginhoux
et al., 2010). However, this receptor con-
tinues to be expressed by microglia in
the adult CNS, raising the possibility that
persistent activation of CSFR1 is required
to sustain their population. To explore
how signaling through this receptor con-
trols the inflammatory response of micro-
glia, Elmore et al. (2014) administered the
CSFR1 inhibitor PLX3397 (Plexxikon) to
adult mice. Remarkably, exposure to this
compound led to a rapid and pronounced
reduction in expression of IBA1, a micro-
glia-specific protein in the brain, below
that seen in untreated controls; after
3 weeks of PLX3397 exposure, brains
were largely devoid of IBA1+ microglia
(Figure 1). Although this might have re-
sulted from an acute reduction in IBA1
expression rather than the disappearance
of microglia, when experiments were per-
formed in transgenic mice in which micro-
glia express GFP (CX3CR1-GFP+/– mice),
CSFR1 inhibition induced a similar deple-
tion of GFP+ cells. Moreover, brains from
these mice exhibited reductions in mi-
croglia-enriched mRNAs, such as AIF1
(which encodes IBA1), CSF1R, CX3CR1,254 Neuron 82, April 16, 2014 ª2014 ElsevierFCGR1, ITGAM, and TREM2. Microglia
continue to divide at a low rate in the
adult CNS; however, this drug-induced
depletion resulted primarily from acceler-
ated death, rather than reduced prolifera-
tion, as there was an increase in activated
caspase-3+ and propidium iodide+ micro-
glia after exposure to PLX3397. These
findings indicate that microglia require
CSFR1 signaling for survival in the
adult CNS.
Despite the widespread death of micro-
glia in this condition, the brain appeared
remarkably unperturbed: brain volume
was unchanged, the blood-brain barrier
remained intact, and there was no global
increase in inflammation. The exception
was a marked increase in S100b and
GFAP expression, a characteristic of
reactive astrocytes, although other fea-
tures of astrocytosis, such as hypertrophy
and enhanced proliferation, were surpris-
ingly absent. This suggests that death
of microglia alone, as occurs after CNS
injury, is not sufficient to provoke an in-
flammatory response. Similar observa-
tions were reported in a recent study by
Parkhurst et al. (2013), in which microglia
were ablated through transgenic expres-
sion of the diphtheria toxin receptor.
The ability to deplete specific cell clas-
ses using chemical agents or genetic
means (i.e., exposure to saporin-linked
ligands or expression of diphtheria toxin),
has helped to define their roles in vivo
and explore the response of remaining
cells. Here, Elmore et al. (2014) sub-
jected mice depleted of microglia with
PLX3397 to a battery of behavioral tests.
Remarkably, short- (7 days) or long-termInc.(2 months) depletion of microglia did not
result in overt behavioral abnormalities or
reduced performance on standard tests
of anxiety (elevated plus maze and open
field), locomotion (accelerating rotarod),
or learning and memory tasks (Barnes
maze). Adult mice depleted of microglia
actually performed slightly better on the
learning andmemory task. Recent studies
show that mice exhibiting a transient
reduction of microglia during develop-
ment due to the loss of the fractalkine re-
ceptor (Cx3cr1) display reduced synaptic
connectivity anddeficits in social behavior
(Zhan et al., 2014), raising the possibility
that microglia play different roles in the
developing andmature brain. The findings
of Elmore et al. (2014) run also counter to
those of Parkhurst et al. (2013), in which
adult microglia-deficient mice performed
worseonmultiple learning tasks, including
rotarod, and exhibited reduced synapse
formation after motor learning. How-
ever, the deficits in motor performance
observed by Parkhurst et al. (2013) were
observed with much more intensive
training, raising the possibility that the
consequences of microglia depletion on
motor learning only manifest in response
to more challenging protocols. Addi-
tionally, CSFR1 inhibition triggers loss of
bothCNSmicroglia andperipheralmacro-
phages, whereas the approach used by
Parkhurst et al. (2013) enabled selective
depletion of microglia. This added manip-
ulation of peripheral cells could have
masked a CNS phenotype. In light of the
modest behavioral changes observed
in mice treated with PLX3397, it will be
important to determine whether they
Neuron
Previewsexhibit deficits in dendritic spine remodel-
ing similar to those observed after genetic
ablation of microglia.
Although microglia remained depleted
inmicemaintained onPLX3397 for several
months, cessation of CSFR1 inhibition
resulted in rapid repopulation of the
brain, and within 14 days microglia were
restored to their normal density (Figure 1).
Howaremicroglia repopulated so rapidly?
Previous studies using a model of micro-
glia depletion induced by thymidine
kinase + gancyclovir revealed that periph-
eral macrophages can masquerade as
microglia after invading the CNS when
the BBB is disrupted (Varvel et al., 2012).
However, CSFR1 inhibition did not disrupt
the BBB, macrophage-specific mRNAs
were not increased, and CCR2+ or
Cd11b+ macrophages were not detected
during repopulation. Moreover, in mice
engineered to express RFP in macro-
phages (CCR2-RFP mice), no RFP+ cells
were observed in the brain after repopula-
tion, suggesting that repopulation occurs
from within the brain.
As shown by Parkhurst et al. (2013), mi-
croglia, like oligodendrocyte progenitors
(Hughes et al., 2013), exhibit homeostasis
and are stimulated to divide and reestab-
lish their normal density if depleted. Thus,
repopulation could simply reflect prolif-
eration of the microglia that survive
CSFR1 inhibition. However, Elmore et al.
(2014) find that proliferating cells present
3 days after cessation of PLX3397
exhibited less complex morphologies
than microglia, were IBA1–, and ex-
pressedmarkers of stem/progenitor cells,
including nestin and CD45. These results
raise the possibility that this remarkable
homeostatic response is catalyzed, in
part, by the mobilization of a latent pool
of hematopoietic progenitors that are
widely distributed throughout the CNS.
This widespread appearance of microglial
progenitors suggests that theymay reside
in a perivascular niche. This regeneration
of microglia recapitulates some aspects
of normal development, as microglia
progenitors transiently express nestin. A
detailed profiling of gene expression by
these regenerated cells may yield further
clues about their origin.What if CSRF1inhibition simply induces
dedifferentiation of microglia? This could
explain the rapid ‘‘loss’’ and reemergence
of microglia when CSFR1 inhibition is
removed and the corresponding changes
in microglia-specific gene expression.
However, this hypothesis is inconsistent
with the increase in apoptotic microglia
in the presence of PLX3397 and the in-
crease in proliferating nestin+ cells, unless
more complex scenarios occur, involving
both death of microglia and dedifferentia-
tion of survivors. One way to define the
lineage of microglia that appears during
repopulation is to perform in vivo fate
tracing. Here, Elmore et al. (2014) labeled
microglia by allowing repopulation
to occur in the presence of BrdU, a
thymidine analog that is permanently
incorporated during DNA replication.
Subsequent readministration of PLX3397
resulted in the loss of BrdU+ cells, sug-
gesting that death rather than dedifferen-
tiation accounts for the disappearance of
microglia.
Homeostasis is a critical feature of dy-
namic cells, which must be maintained
at an optimum density to ensure proper
organ and tissue function. This rapid
recruitment of microglial progenitors
throughout the brain was unexpected,
given the myeloid origin of microglia and
the intrinsic ability of resident microglia
to proliferate. Parallels can again be
drawn with oligodendrocyte progenitors,
which exhibit their own homeostatic pro-
liferation after depletion (Hughes et al.,
2013; Robins et al., 2013) but can also
be replaced through recruitment of latent
progenitors within the SVZ after injury or
demyelination (Menn et al., 2006). The
different modes of repopulation observed
in different models of microglia depletion,
involving infiltration of macrophages,
proliferation of endogenous microglia, or
recruitment of latent progenitors, highlight
that there are redundant mechanisms to
ensure that their functions are preserved.
It remains to be determined whether the
nestin+ progenitors that emerge in this
depletion model also contribute to the
normal homeostasis of microglia in the
adult CNS and whether pathological
changes in CSFR1 ligands CSF or IL-34Neuronalter the ability of microglia to partici-
pate in repair. Defining the mechanisms
responsible for this cellular homeostasis
would be further aided by genetic line-
age-tracing studies and continuous
monitoring of microglia in vivo using
two-photon imaging. This discovery that
CSFR1 inhibition by PLX3397 depletes
microglia in the adult CNS provides a
valuable new tool to help define the role
of these dynamic glial cells in both CNS
repair and cognitive function.REFERENCES
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